Peritoneal mesothelioma in a woman who has survived for seven years: a case report.
BACKGROUND
Malignant peritoneal mesothelioma is a rare cancer with poor patient survival. Female gender has been identified as a positive prognostic factor. Recently, it has been suggested that the expression of estrogen receptor β in malignant mesothelioma leads to tumor suppression and a better prognosis.


METHODS
We report the case of a 48-year-old Caucasian woman who is alive and disease-free seven years after the initial diagnosis and treatment of malignant peritoneal mesothelioma.


CONCLUSIONS
This patient's long survival may be attributable to a combination of factors, including minimal disease, complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy plus the estrogen receptor β positivity of the tumor.
Department of Surgery, St, George Hospital, University of New South Wales, Kogarah, NSW, Australia. mh.pourgholami@unsw.edu.au.
Krishna
K
Pillai
Javed
J
Akhter
Mohammad H
MH
Pourgholami
David L
DL
Morris
Cancer Res. 2009 Jun 1;69(11):4598-604
19487281
Cancer. 2007 Apr 15;109(8):1454-61
17348013
Ann Oncol. 2007 Jun;18(6):985-90
17030547
J Clin Oncol. 2005 Mar 10;23(8):1616-22
15755967
Curr Treat Options Oncol. 2002 Oct;3(5):375-86
12194803
Cancer Res. 2005 Nov 15;65(22):10273-9
16288015
J Med Case Rep. 2008 Apr 25;2:121
18439258
Can J Surg. 2009 Feb;52(1):59-64
19234654
J Clin Oncol. 2003 Dec 15;21(24):4560-7
14673042
MedGenMed. 2007 May 10;9(2):32
17955087